Ironwood Pharmaceuticals (IRWD) Leases (2016 - 2025)
Ironwood Pharmaceuticals (IRWD) has disclosed Leases for 16 consecutive years, with $9.3 million as the latest value for Q4 2025.
- Quarterly Leases fell 15.31% to $9.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.3 million through Dec 2025, down 15.31% year-over-year, with the annual reading at $9.3 million for FY2025, 15.31% down from the prior year.
- Leases hit $9.3 million in Q4 2025 for Ironwood Pharmaceuticals, down from $9.8 million in the prior quarter.
- In the past five years, Leases ranged from a high of $16.3 million in Q1 2021 to a low of $9.3 million in Q4 2025.
- Historically, Leases has averaged $13.0 million across 5 years, with a median of $13.1 million in 2023.
- Biggest five-year swings in Leases: decreased 6.69% in 2021 and later dropped 15.31% in 2025.
- Year by year, Leases stood at $15.4 million in 2021, then dropped by 8.64% to $14.0 million in 2022, then decreased by 10.25% to $12.6 million in 2023, then fell by 12.38% to $11.0 million in 2024, then decreased by 15.31% to $9.3 million in 2025.
- Business Quant data shows Leases for IRWD at $9.3 million in Q4 2025, $9.8 million in Q3 2025, and $10.2 million in Q2 2025.